LAVA Therapeutics Q3 EPS $(0.34) Down From $0.04 YoY
Portfolio Pulse from Benzinga Newsdesk
LAVA Therapeutics (NASDAQ:LVTX) reported a significant decrease in earnings, with Q3 EPS at $(0.34), down from $0.04 YoY, marking a 950% decrease.
November 16, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
LAVA Therapeutics reported a substantial decline in Q3 earnings per share, with a 950% decrease compared to the same period last year.
The reported 950% decrease in earnings per share is a significant negative financial performance indicator, which is likely to impact investor sentiment and the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100